BioTrove, Gene Express Awarded NCI Grant to Co-Develop Lung Cancer Risk Dx Platform | GenomeWeb
NEW YORK (GenomeWeb News) – BioTrove and Gene Express said today that they have been awarded a two-year grant from the National Cancer Institute to develop a genetic profiling test for the risk of lung cancer in collaboration with Mount Sinai School of Medicine.
 
The researchers will combine BioTrove’s OpenArray PCR platform, Gene Express’ PCR standards, and Mount Sinai’s clinical knowledge to study genetic biomarkers linked to lung cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.